SEC Form 4 · accession 0001140361-17-000843
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank Corvino
Director
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 3, 2017 | M | 7,500 | $14.00 | A | 7,500 | D | |
| Common Stock | Jan 3, 2017 | M | 12,500 | $14.00 | A | 20,000 | D | |
| Common Stock | Jan 3, 2017 | M | 15,000 | $25.39 | A | 35,000 | D | |
| Common StockF1 | Jan 3, 2017 | S | 31,400 | $40.2496 | D | 3,600 | D | |
| Common StockF2 | Jan 3, 2017 | S | 3,600 | $41.0063 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3 | $14.00 | Jan 3, 2017 | M | 7,500 | D | — | Jul 30, 2024 | Common Stock | 7,500 | 0 | D |
| Stock Option (right to buy)F4 | $14.00 | Jan 3, 2017 | M | 12,500 | D | — | Jul 30, 2024 | Common Stock | 12,500 | 12,500 | D |
| Stock Option (right to buy)F3 | $25.39 | Jan 3, 2017 | M | 15,000 | D | — | Mar 26, 2025 | Common Stock | 15,000 | 0 | D |
| Stock Option (right to buy)F5 | $21.27 | holding | — | — | — | — | Feb 1, 2026 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.98 to $40.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.99 to $41.07, inclusive.
- F3The option is immediately exercisable.
- F4The option became exercisable as to 6,250 shares on June 30, 2015 and as to 6,250 on June 30, 2016. The option becomes exercisable as to the remaining 12,500 shares in two equal installments of 6,250 shares on June 30, 2017 and 2018.
- F5The option became exercisable as to 7,500 shares upon the reporting person's reelection to the issuer's board of directors at the issuer's 2016 Annual Meeting of Stockholders held on June 23, 2016. The remaining 7,500 shares will become exercisable on January 31, 2017; provided, that the reporting person continues to serve as a director of the issuer through such date.
Remarks
Exhibit List: Exhibit 24 - Power of Attorney